CD33 and viral hepatitis: Despite observing a significant influence of CD33 SNPs on individuals with viral hepatitis, our analysis did not identify any significant differences in cognitive functions among Parkinson’s disease participants with different genotypes (Table 4 and Supplementary Table 6(b)).